Startseite Novel non-stop variant of the NR0B1 gene in two siblings with adrenal hypoplasia congenita
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Novel non-stop variant of the NR0B1 gene in two siblings with adrenal hypoplasia congenita

  • Tomoko Ota EMAIL logo , Noriyuki Katsumata , Yasuhiro Naiki und Reiko Horikawa
Veröffentlicht/Copyright: 14. Juli 2022

Abstract

Objectives

Mutations in the dosage-sensitive sex reversal-AHC critical region on the X chromosome, gene 1 (DAX-1, officially NR0B1), cause X-linked adrenal hypoplasia congenita (AHC) and hypogonadotropic hypogonadism (HHG). Salt-losing adrenal insufficiency usually occurs during the neonatal period or early childhood. We report a novel non-stop variant of NR0B1 in two siblings and their unusual clinical course.

Case presentation

The proband was a boy who presented with an unusual form of AHC with neonatal onset of growth failure and mild salt loss, but without cutaneous pigmentation or plasma ACTH elevation. His 4-year-old elder brother had been growing healthily, but carried an AHC diagnosis. A non-stop variant of NR0B1 (p.*471K) was demonstrated in the patients and their mother.

Conclusions

We identified a novel non-stop variant of NR0B1 in two siblings. Mild salt loss associated with hyperkalemia is a crucial diagnostic clue for AHC, even without apparent symptoms of glucocorticoid deficiency.


Corresponding author: Tomoko Ota, Division of Endocrinology and Metabolism, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku 157-8535, Tokyo, Japan, Phone: +81 3 3416 0181, Fax: +81 3 3416 2222, E-mail:

Funding source: JSPS KAKENHI

Award Identifier / Grant number: 16K10005 (to YN and NK) and JP17K10091 (to NK)

Funding source: a Health and Labor Sciences Research Grant for research on intractable diseases from the Ministry of Health, Labor and Welfare of Japan

Award Identifier / Grant number: Nanbyo-Ippan-046 to NK

Acknowledgments

The authors thank the patient’s family for genetic testing. The authors also thank Ms. Atsuko Nagashima–Miyokawa for her excellent technical assistance.

  1. Research funding: This work was supported by JSPS KAKENHI Grant Numbers 16K10005 (to YN and NK) and JP17K10091 (to NK) and a Health and Labor Sciences Research Grant for research on intractable diseases from the Ministry of Health, Labor and Welfare of Japan (Nanbyo-Ippan-046 to NK).

  2. Author contribution: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: The authors declare no conflicts of interest.

  4. Informed consent: Written informed consent for the genetic analysis and publication was obtained from the parents.

  5. Ethical approval: The genetic study was approved by the Institutional Ethics Review Board at the National Center for Child Health and Development.

References

1. Zanaria, E, Muscatelli, F, Bardoni, B, Strom, TM, Guioli, S, Guo, W, et al.. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 1994;372:635–41. https://doi.org/10.1038/372635a0.Suche in Google Scholar PubMed

2. Seminara, SB, Achermann, JC, Genel, M, Jameson, JL, Crowley, WF. X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females. J Clin Endocrinol Metab 1999;84:4501–9. https://doi.org/10.1210/jcem.84.12.6172.Suche in Google Scholar PubMed

3. Wiltshire, E, Couper, J, Rodda, C, Jameson, JL, Achermann, JC. Variable presentation of X-linked adrenal hypoplasia congenita. J Pediatr Endocrinol Metab 2001;14:1093–6. https://doi.org/10.1515/jpem-2001-0804.Suche in Google Scholar PubMed

4. Goto, M, Katsumata, N. X-linked adrenal hypoplasia congenita caused by a novel intronic mutation of the DAX-1 gene. Horm Res 2009;71:120–4. https://doi.org/10.1159/000183901.Suche in Google Scholar PubMed

5. Bansal, S, Castells, S, Umpaichitra, V, Perez-Colon, S. Presence of 21-hydroxylase antibodies in a boy with X-linked adrenal hypoplasia congenita. Horm Res Paediatr 2015;84:408–13. https://doi.org/10.1159/000440803.Suche in Google Scholar PubMed

6. Khattab, A, Nelson-Williams, C, Cabreza, V, Macdonald, A, Loring, E, Saland, J, et al.. A novel de novo frameshift mutation in NR0B1 and low prenatal estriol in adrenal hypoplasia congenita. Ann N Y Acad Sci 2018;1433:7–11. https://doi.org/10.1111/nyas.13962.Suche in Google Scholar PubMed

7. Iughetti, L, Lucaccioni, L, Bruzzi, P, Ciancia, S, Bigi, E, Madeo, SF, et al.. Isolated hypoaldosteronism as first sign of X-linked adrenal hypoplasia congenita caused by a novel mutation in NR0B1/DAX-1 gene: a case report. BMC Med Genet 2019;20:98. https://doi.org/10.1186/s12881-019-0834-7.Suche in Google Scholar PubMed PubMed Central

8. Al Amer, AM, Al Rubaya, KM, Alzahrani, AS. Adrenal hypoplasia congenita in identical twins. Saudi Med J 2019;40:87–92. https://doi.org/10.15537/smj.2019.1.23337.Suche in Google Scholar PubMed PubMed Central

9. Sekiguchi, Y, Hara, Y, Matsuoka, H, Hayashi, Y, Katsumata, N, Hirata, Y. Sibling cases of Addison’s disease caused by DAX-1 gene mutations. Intern Med 2007;46:35–9. https://doi.org/10.2169/internalmedicine.46.6082.Suche in Google Scholar PubMed

10. Lek, M, Karczewski, KJ, Minikel, EV, Samocha, KE, Banks, E, Fennell, T, et al.. Analysis of protein-coding genetic variation in 60, 706 humans. Nature 2016;536:285–91. https://doi.org/10.1038/nature19057.Suche in Google Scholar PubMed PubMed Central

11. Auton, A, Brooks, LD, Durbin, RM, Garrison, EP, Kang, HM, Korbel, JO, et al.. A global reference for human genetic variation. Nature 2015;526:68–74.10.1038/nature15393Suche in Google Scholar PubMed PubMed Central

12. Sudmant, PH, Rausch, T, Gardner, EJ, Handsaker, RE, Abyzov, A, Huddleston, J, et al.. An integrated map of structural variation in 2,504 human genomes. Nature 2015;526:75–81. https://doi.org/10.1038/nature15394.Suche in Google Scholar PubMed PubMed Central

13. Ellison, J. Gene symbol: NR0B1. Hum Genet 2007;121:297.Suche in Google Scholar


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/jpem-2022-0120).


Received: 2022-03-06
Accepted: 2022-06-23
Published Online: 2022-07-14
Published in Print: 2022-09-27

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review Article
  3. Effects and dose-response relationships of exercise intervention on weight loss in overweight and obese children: a meta-regression and system review
  4. Original Articles
  5. Diabetic ketoacidosis in children with new-onset type 1 diabetes mellitus: demographics, risk factors and outcome: an 11 year review in Hong Kong
  6. Incidence tendency, etiological classification and outcome of congenital hypothyroidism in Guangzhou, China: an 11-year retrospective population-based study
  7. Metabolically healthy obesity in a paediatric obesity clinic
  8. Universal salt iodization potentially contributes to health equity: socio-economic status of children does not affect iodine status
  9. Association between clinical variations and copy number variations in cases with Turner syndrome
  10. The mediating function of obesity on endocrine-disrupting chemicals and insulin resistance in children
  11. Relationship between prolactin level and puberty in girls with early breast development
  12. Pattern of presentation of paediatric endocrine disorders in a Nigerian tertiary institution: an 11-year survey
  13. Case Reports
  14. Novel non-stop variant of the NR0B1 gene in two siblings with adrenal hypoplasia congenita
  15. Identification of two novel ACAT1 variant associated with beta-ketothiolase deficiency in a 9-month-old boy
  16. Craniosynostosis in a patient with Fanconi–Bickel syndrome: a case report
  17. Severe loss of adipose tissue in a Vietnamese lipodystrophy patient caused by LMNA p.G465D mutation: a first clinical characterization and two-year follow-up
  18. The response to growth hormone treatment in a child with short stature, growth hormone deficiency and autosomal dominant cutis laxa type 3 – case report
  19. Novel homozygous inactivating mutation in the luteinizing hormone receptor gene (LHCGR) associated with 46, XY DSD in a Moroccan family
Heruntergeladen am 17.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2022-0120/html
Button zum nach oben scrollen